SBFM vs. ASTS
SBFM (Sunshine Biopharma Inc) and ASTS (AST SpaceMobile, Inc.) are both stocks. SBFM operates in Drug Manufacturers - Specialty & Generic (Healthcare), while ASTS operates in Communication Equipment (Technology). Over the past 5 years, SBFM returned -77.19%/yr vs 50.21%/yr for ASTS. At a 0.11 correlation, their price movements are largely independent.
Performance
SBFM vs. ASTS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBFM achieves a -83.33% return, which is significantly lower than ASTS's 0.77% return.
SBFM
- 1D
- -3.76%
- 1M
- -57.41%
- YTD
- -83.33%
- 6M
- -85.14%
- 1Y
- -85.76%
- 3Y*
- -94.10%
- 5Y*
- -77.19%
- 10Y*
- -51.42%
ASTS
- 1D
- -9.26%
- 1M
- -30.86%
- YTD
- 0.77%
- 6M
- -15.37%
- 1Y
- 59.32%
- 3Y*
- 120.25%
- 5Y*
- 50.21%
- 10Y*
- —
SBFM vs. ASTS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SBFM Sunshine Biopharma Inc | -83.33% | -59.00% | -99.45% | -57.58% | 994.95% | -51.29% |
ASTS AST SpaceMobile, Inc. | 0.77% | 244.22% | 249.92% | 25.10% | -39.29% | -31.73% |
Correlation
The correlation between SBFM and ASTS is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Apr 7, 2021 | 0.11 |
Fundamentals
SBFM:
$8.52M
ASTS:
$21.28B
SBFM:
-$1.98
ASTS:
-$1.84
SBFM:
0.17
ASTS:
228.68
SBFM:
0.37
ASTS:
8.00
SBFM:
$36.31M
ASTS:
$84.94M
SBFM:
$12.26M
ASTS:
-$22.93M
SBFM:
-$5.62M
ASTS:
-$536.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBFM vs. ASTS — Risk / Return Rank
SBFM
ASTS
SBFM vs. ASTS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sunshine Biopharma Inc (SBFM) and AST SpaceMobile, Inc. (ASTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBFM | ASTS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -2.88 | ||
| Omega ratioGain probability vs. loss probability | 0.78 | 1.17 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.95 | 1.25 | -2.20 |
| Martin ratioReturn relative to average drawdown | -1.98 | 2.38 | -4.36 |
Loading charts...
Drawdowns
SBFM vs. ASTS - Drawdown Comparison
The maximum SBFM drawdown since its inception was -100.00%, which is greater than ASTS's maximum drawdown of -85.57%. Use the drawdown chart below to compare losses from any high point for SBFM and ASTS.
Loading charts...
Drawdown Indicators
| SBFM | ASTS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -85.57% | -14.43% |
Max Drawdown (1Y)Largest decline over 1 year | -90.68% | -47.69% | -42.99% |
Max Drawdown (3Y)Largest decline over 3 years | -99.98% | -70.66% | -29.32% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -85.57% | -14.43% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -45.01% | -54.99% |
Average DrawdownAverage peak-to-trough decline | -88.84% | -40.50% | -48.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.21% | 25.02% | +18.19% |
Volatility
SBFM vs. ASTS - Volatility Comparison
Sunshine Biopharma Inc (SBFM) has a higher volatility of 56.48% compared to AST SpaceMobile, Inc. (ASTS) at 42.16%. This indicates that SBFM's price experiences larger fluctuations and is considered to be riskier than ASTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBFM | ASTS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 56.48% | 42.16% | +14.32% |
Volatility (6M)Calculated over the trailing 6-month period | 117.37% | 83.93% | +33.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 129.50% | 106.17% | +23.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6,611.20% | 109.65% | +6,501.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 4,763.88% | 110.98% | +4,652.90% |
Dividends
SBFM vs. ASTS - Dividend Comparison
Neither SBFM nor ASTS has paid dividends to shareholders.
Financials
SBFM vs. ASTS - Financials Comparison
This section allows you to compare key financial metrics between Sunshine Biopharma Inc and AST SpaceMobile, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SBFM and ASTS have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBFM has higher volatility (56.48%) compared to ASTS (42.16%). In terms of maximum drawdown, SBFM dropped -100.00% vs ASTS's -85.57%.
ASTS currently has the higher Sharpe Ratio (0.56 vs -0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBFM and ASTS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer